Corbus Pharmaceuticals Holdings (CRBP) EBITDA Margin (QoQ) (2015 - 2021)
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) EBITDA Margin (QoQ) (2015 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 101.29 Mn | -61.98 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | -202,706.00 |
| Jun 30, 2021 | -985,063.00 |
| Mar 31, 2021 | 78,260.00 |
| Dec 31, 2020 | -40,127.00 |
| Sep 30, 2020 | 1.06 Mn |
| Jun 30, 2020 | -1.16 Mn |
| Mar 31, 2020 | -63,950.00 |
| Dec 31, 2019 | -8,748.00 |
| Sep 30, 2019 | -97,493.00 |
| Jun 30, 2019 | 141,240.00 |
| Mar 31, 2019 | -49,381.00 |
| Dec 31, 2018 | 45,296.00 |
| Sep 30, 2018 | 8,617.00 |
| Jun 30, 2018 | -20,350.00 |
| Sep 30, 2017 | 120,857.00 |
| Jun 30, 2017 | -150,613.00 |
| Sep 30, 2016 | 33,860.00 |
| Jun 30, 2016 | -32,890.00 |
| Mar 31, 2016 | -4,152.00 |
| Dec 31, 2015 | 63,642.00 |